SCHEMBL8266650

SCHEMBL8266650

COC1=CC=C(N(C(=O)c2cnc(N3CCOCC3)nc2-c2ccccc2F)C(C)C)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.37
▸ PTPN11 Q06124 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ BCR P11274 1/20 0.36
▸ WDR5 P61964 1/20 0.35
▸ CASP1 P29466 5/20 0.35
▸ CASP7 P55210 5/20 0.35
▸ CYP1A2 P05177 5/20 0.35
▸ USP2 O75604 4/20 0.35
▸ ALDH1A1 P00352 4/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ PIK3CA P42336 5/20 0.35
▸ PIK3R1 P27986 1/20 0.35
▸ TACR1 P25103 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HIF1A Q16665 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11923285 0.85 CYP1A2 (0.44) WDR5CASP1CASP7CYP1A2USP2
SCHEMBL11923223 0.84 PTPN11 (0.43) AOC3PTPN11ABL1BCRWDR5
SCHEMBL11923270 0.83 WDR5 (0.43) WDR5CASP1CASP7CYP1A2USP2
SCHEMBL11923217 0.80 PIK3CA (0.40) AOC3PTPN11ABL1BCRCASP1
SCHEMBL8267659 0.80 WDR5 (0.44) AOC3PTPN11ABL1BCRWDR5
SCHEMBL11923212 0.79 PIK3CA (0.38) AOC3PTPN11ABL1BCRWDR5
SCHEMBL11923275 0.78 TACR1 (0.40) AOC3PTPN11ABL1BCRWDR5
SCHEMBL8266903 0.78 OGA (0.38) AOC3PTPN11ABL1BCRWDR5
SCHEMBL8268304 0.78 ALDH1A1 (0.42) PTPN11ABL1BCRWDR5CASP1
SCHEMBL11923282 0.77 LMNA (0.38) ABL1BCRWDR5ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050476-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-05-11 — — WO disclosed
Send feedback